Cohance Lifesciences Limited
COHANCE
Classement en actions
#6385
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Prix de l'action
$5.05
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$1.93B
Changement (1 jour)
-1.44%
Changement (1 an)
-57.38%
Pays
IN
Échange Cohance Lifesciences Limited (COHANCE)
Catégorie
Healthcare
Historique du rendement du dividende pour Cohance Lifesciences Limited (COHANCE)
Le rendement du dividende (TTM) de Cohance Lifesciences Limited (symbole boursier : COHANCE) au 2024-03-31 est : 0.00%
Rendement moyen du dividende sur les 5 dernières années : 0.51%
Rendement moyen du dividende sur les 5 dernières années : 0.51%
Historique du rendement du dividende de Cohance Lifesciences Limited (COHANCE) de 2019 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | 1.69% | 160.00% |
| 2022 | 0.65% | 225.00% |
| 2021 | 0.20% | -93.33% |
| 2020 | 3.00% | 455.56% |
| 2019 | 0.54% | 0.00% |
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
